Literature DB >> 26291897

An In vivo Wound Model Utilizing Bacteriophage Therapy of Pseudomonas aeruginosa Biofilms.

Somprakas Basu1, Manav Agarwal1, Satyanam Kumar Bhartiya1, Gopal Nath1, Vijay Kumar Shukla1.   

Abstract

Bacteriophages have been used as effective therapy against bacterial biofilms on devices such as catheters, in the lungs such as in cystic fibrosis, and even in infected food. Unlike antibiotics, they are bacteria-specific and produce the desired effect without systemic complications; they can develop bacterial resistance, although in ways different from antibiotics. The present study aimed to assess the effect of bacteriophages against multidrug-resistant Pseudomonas aeruginosa in a mouse wound model. P. aeruginosa obtained from laboratory culture of burn wounds were characterized, harvested, and titrated, and biofilms were generated on sterile catheter sections (105 colony forming units/mL). Subcutaneous pockets were created on the backs of 24 male albino mice. Animals were randomized into 4 groups of 6 each. After evaluating a significant phage-bacteria interaction in vitro, 2 biofilm-laden catheter sections were implanted in subcutaneous pockets in mouse groups C and D. Sterile catheter sections only were implanted in group B. Group A had only a subcutaneous pocket without any catheter section. Phage cocktail solutions (10 \'b5L of 107 phage forming units/mL) were injected daily in group D pockets only. Groups B and C received 10 \'b5L of normal saline. After 10 days, the catheter sections were explanted from groups B, C, and D and tissue biopsy was taken from group A pockets and cultured for bacterial and phage colony counts. A significant drop in bacterial counts from 3.87 x 106 to 3.52 x 104 was observed in group D when compared with group C (3.87 x 106 to 3.85 x 105, P less than 0.05) A significant rise in the phage counts from 1 x 107 to 6.81 x 108 (P less than 0.05) also was observed in group D when compared with the baseline counts, indicating active phage proliferation and successful bacterial kill in group D. The present laboratory study could be indicative of a new treatment approach for multidrug-resistant bacterial infections, including wound infections.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26291897

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  6 in total

Review 1.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

Review 2.  Phage therapy against Enterococcus faecalis in dental root canals.

Authors:  Leron Khalifa; Mor Shlezinger; Shaul Beyth; Yael Houri-Haddad; Shunit Coppenhagen-Glazer; Nurit Beyth; Ronen Hazan
Journal:  J Oral Microbiol       Date:  2016-09-16       Impact factor: 5.474

Review 3.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

4.  Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model.

Authors:  Nouran Rezk; Abdallah S Abdelsattar; Doaa Elzoghby; Mona M Agwa; Mohamed Abdelmoteleb; Rania G Aly; Mohamed S Fayez; Kareem Essam; Bishoy M Zaki; Ayman El-Shibiny
Journal:  J Genet Eng Biotechnol       Date:  2022-09-12

Review 5.  Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.

Authors:  Zahra Chegini; Amin Khoshbayan; Majid Taati Moghadam; Iman Farahani; Parham Jazireian; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-30       Impact factor: 3.944

6.  Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa.

Authors:  Sonika Sharma; Sibnarayan Datta; Soumya Chatterjee; Moumita Dutta; Jhuma Samanta; Mohan G Vairale; Rajeev Gupta; Vijay Veer; Sanjai K Dwivedi
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.